How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Proton Therapy Accelerator Market
- By Type of Accelerator: Cyclotron, Synchrotron, Linear Accelerator (Linac), Fixed-Field Alternating Gradient (FFAG) Accelerator
- By Application: Cancer Treatment, Research and Development, Radiobiology Studies, Particle Physics Experiments
- By End User: Hospitals and Cancer Treatment Centers, Research Institutes, Academic and Medical Universities, Government and Defense Research Facilities
- By Component: Beam Delivery Systems, Gantry Systems, Ion Sources, Control Systems, Vacuum Systems
- By Technology: Single-room Proton Therapy Systems, Multi-room Proton Therapy Systems, Compact Proton Therapy Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cyclotron leads By Type of Accelerator at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Proton Therapy Accelerator Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Type of Accelerator 4
Application 4
End User 4
Component 5
Technology 3
Companies profiled
IBA (Ion Beam Applications)
Varian Medical Systems (a Siemens Healthineers company)
Hitachi Ltd.
Mevion Medical Systems
Sumitomo Heavy Industries
ProTom International
Advanced Oncotherapy
Mitsubishi Electric Corporation
Sumitomo Precision Products
ProNova Solutions
SHI Accelerator Service
Ion Beam Applications (IBA)
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →IBA (Ion Beam Applications)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Varian Medical Systems (a Siemens Healthineers company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Hitachi Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Mevion Medical Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sumitomo Heavy Industries
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ProTom International
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Advanced Oncotherapy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Mitsubishi Electric Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sumitomo Precision Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ProNova Solutions
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →SHI Accelerator Service
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Ion Beam Applications (IBA)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Best Theratronics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →CNAO (Centro Nazionale di Adroterapia Oncologica)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,433M by 2033 · 5.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cyclotron50.9
- Synchrotron16.6
- Linear Accelerator (Linac)19.7
- Fixed-Field Alternating Gradient (FFAG) Accelerator12.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,401M → $1,928M · 4.1%
Europe$976.5M → $1,434M · 4.9%
Asia Pacific$891.6M → $1,215M · 3.9%
Latin America$552.0M → $876.0M · 5.9%
Middle East and Africa$424.6M → $671.8M · 5.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.292026
5.292027
5.302028
5.312029
5.332030
5.352031
5.352032
5.382033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- IBA (Ion Beam Applications)18.1
- Varian Medical Systems (a Siemens Healthineers company)22.6
- Hitachi Ltd.10.0
- Mevion Medical Systems7.0
- Sumitomo Heavy Industries6.4
- ProTom International7.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Type of Accelerator12.4%
Application27.0%
End User13.6%
Component13.2%
Technology33.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe23.4
- Asia Pacific19.8
- Latin America14.3
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| IBA (Ion Beam Applications) | 90 | 90 | 79 | 88 | 81 | 78 | 84 |
| Varian Medical Systems (a Siemens Healthineers company) | 78 | 69 | 88 | 75 | 81 | 71 | 77 |
| Hitachi Ltd. | 87 | 78 | 78 | 86 | 83 | 79 | 82 |
| Mevion Medical Systems | 74 | 77 | 60 | 69 | 71 | 67 | 70 |
| Sumitomo Heavy Industries | 74 | 64 | 56 | 72 | 59 | 69 | 66 |
| ProTom International | 53 | 53 | 48 | 59 | 46 | 46 | 51 |
| Advanced Oncotherapy | 56 | 48 | 58 | 55 | 45 | 54 | 53 |
| Mitsubishi Electric Corporation | 39 | 54 | 52 | 48 | 57 | 43 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- IBA (Ion Beam Applications)
- Varian Medical Systems (a Siemens Healthineers company)
- Hitachi Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| IBA (Ion Beam Applications) | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Varian Medical Systems (a Siemens Healthineers company) | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Hitachi Ltd. | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Mevion Medical Systems | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Sumitomo Heavy Industries | ◐ | ◐ | − | − | ◐ | ✓ |
| ProTom International | − | − | ◐ | − | − | ◐ |
| Advanced Oncotherapy | ◐ | − | ◐ | ◐ | − | − |
| Mitsubishi Electric Corporation | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1IBA (Ion Beam Applications)84
2Hitachi Ltd.82
3Varian Medical Systems (a Siemens Healthineers company)77
4Mevion Medical Systems70
5Sumitomo Heavy Industries66
6Advanced Oncotherapy53
7ProTom International51
8Mitsubishi Electric Corporation49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
IBA (Ion Beam Applications)Hitachi Ltd.
Challenger2
Strong scale, closing on the leaders.
Varian Medical Systems (a Siemens Healthineers company)Mevion Medical Systems
Contender1
Focused players with pockets of strength.
Sumitomo Heavy Industries
Niche3
Specialists in a single segment or region.
ProTom InternationalAdvanced OncotherapyMitsubishi Electric Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Type of Accelerator in North America, then scale across Proton Therapy Accelerator Market — a $425M beachhead inside a $7.19B market.
Beachhead (SOM)$425Mobtainable near-term
Serviceable (SAM)$2.46Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Cyclotron
Best fit — highest urgency & budget in Type of Accelerator.
Economic buyer76 fit
Synchrotron
Strong fit — clear ROI and a fast path to value.
End user66 fit
Linear Accelerator (Linac)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Type of Accelerator in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Type of Accelerator leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Proton Therapy Accelerator Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified23%
Evaluation12%
Closed-won8%
$16.5KCAC
$66KLTV
4.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Proton Therapy Accelerator Market is a durable-growth opportunity — $7.35B by 2033, compounding at 6.4%.
TAM · 2025$4.48Btoday
TAM · 2033$7.35Bforecast
CAGR6.4%2027–2033
Cumulative$52.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.35BTotal addressable market
SAM$2.61BServiceable available market
SOM$481MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.4% CAGR
Demand compounds through 2033, outpacing GDP across Type of Accelerator.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Type of Accelerator moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.35BLarge & growingTAM by 2033 at 6.4% CAGR
$2.61BServiceable nowreachable with today’s model
$481MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.73BBear4.1% CAGR
$7.35BBase6.4% CAGR
$9.41BBull8.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Proton Therapy Accelerator Market — a $5.21B market by 2033. Plan: grow share from 7.5% to 13.6%.
Market size · 2033$5.21Btotal addressable
Market CAGR7.9%2027–2033
Target share13.6%from 7.5% today
Revenue ambition$708Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.5% | 13.6% | Behind |
| Revenue | $356M | $708M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.0% | 44.0% | On track |
| Customer retention | 86.8% | 94.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Type of Accelerator
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Type of Accelerator share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $85M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Type of Accelerator leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Proton Therapy Accelerator Market conversation — a $3.82B market you can size, segment and defend in minutes.
Market size · 2033$3.82Btotal opportunity
Growth9.5%CAGR to 2033
Addressable buyers1,429+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Type of Accelerator
Goal Grow share in Type of Accelerator
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 3 mopayback period
$98K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
IBA (Ion Beam Applications)Varian Medical Systems (a Siemens Healthineers company)Hitachi Ltd.Mevion Medical SystemsSumitomo Heavy IndustriesProTom InternationalAdvanced OncotherapyMitsubishi Electric Corporation+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Proton Therapy Accelerator Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Proton Therapy Accelerator Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Proton Therapy for Cancer Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportProton Therapy in Cancer Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportProton Therapy Synchrotron Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportProton Therapy System Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportProtonic Ceramic Fuel Cell Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportProtopine Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportProtractors & Squares Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportProustite Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportProvider Data Management (PDM) Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportProving Ring Penetrometer Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportProvisional Materials - Indirect Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportProvitamins and Vitamins Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.